SEPARATIVE Announces Investment by Agilent
SEPARATIVE, start-up developing a ground-breaking technology for preparative chromatography, was awarded at SME Instrument phase 1.
Created in 2014, SEPARATIVE develops a new molecular separation technology based on a ground-breaking multicapillary material. This new material breaks with the state-of-the-art chromatography. It was inhibited for decades by the operating pressure inerrant to current technologies. SEPARATIVE multicapillary chromatography columns operate at a pressure 10 to 30 times lower than current columns.
The potential for value creation is four types:
The multiplication of the separation power, likely to generate growth drivers for all chemical industries in particular for pharmaceutical, biotechnologies, cosmetics, aromas, oil and nuclear;
The time reduction of each operation of analysis or purification making it possible to increase considerably laboratory and factory productivity;
The investment reduction in equipment which can reach a factor of 10;
A more ecological chromatography that respects the health of employees thanks to a two to four reduction factor in the consumption of flammable and toxic solvents.
SEPARATIVE initially targets the healthcare market and develops HPLC preparative chromatography columns that can be used on Flash equipment. The technology can be applied to all types of chromatography and SEPARATIVE is looking for partners to co-develop the product ranges.
By accessing phase 1 of the SME Instrument program, SEPARATIVE must meet a double challenge: finalize the industrialization of prototype production and position itself in the value chain of laboratory equipment manufacturers through the development of partnerships. The aim is to be able to produce daily around ten preparative prototypes and to start selling to manufacturers.
For more information:
About Separative: www.separative.net
About the SME Instrument program: click here